Diabetic nephropathy in 2010: Alleviating the burden of diabetic nephropathy

Nature Reviews Nephrology

Volumn 7, Issue 2, 2011, Pages 71-73

  Gray, Stephen P ^a   Cooper, Mark E ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BENFOTIAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; THIAMINE;

DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG MEGADOSE; GLYCEMIC CONTROL; HUMAN; HYPERINSULINEMIA; KIDNEY BIOPSY; KIDNEY FAILURE; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROTEOMICS; RENAL REPLACEMENT THERAPY; REVIEW;

COST OF ILLNESS; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 79551546008     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2010.176     Document Type: Review

References (10)

1. Papale, M. et al. Urine proteome analysis may allow non-invasive differential diagnosis of diabetic nephropathy. Diabetes Care 33, 2409-2415 (2010).
2. Overgaard, A. J. et al. Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy Proteome Science 8, 4(2010).
3. Babaei-Jadidi, R., Karachalias, N., Ahmed, N., Battah, S. & Thornalley, P J. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 52, 2110-2120 (2003).
4. Alkhalaf, A. et al. A double-blind, randomized, placebo controlled clinical trial on benfotiamine treatment in patietns with diabetic nephropathy. Diabetes Care 33, 1598-1601 (2010).
5. Rabbani, N. et al. High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study. Diabetologia 52, 208-212 (2009).
6. Ismail-Beigi, F. et al. Effect of intensive treatment of hyperglycemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376, 419-30 (2010).
7. Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R. & Neil, H. A. 10-year follow-up of intensive glucose control type 2 diabetes. N. Engl. J. Med. 359, 1577-1589 (2008).
8. Zoungas, A. et al. Intensive glucose control is renoprotective in type 2 diabetes: new analyses from ADVANCE. Diabetologia 53 (Suppl. 1), S98 (2010).
9. Duckworth, W. et al. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360, 129-139 (2009).
10. Tessari, P. et al. Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy. Diabetes 59, 2152-2159 (2010).